Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
11,088,335
-
Shares change
-
+173,527
-
Total reported value, excl. options
-
$13,748,000
-
Value change
-
+$1,297,526
-
Number of buys
-
18
-
Number of sells
-
-14
-
Price
-
$1.24
Significant Holders of ZOSANO PHARMA CORP - COM NEW (ZSAN) as of Q1 2021
40 filings reported holding ZSAN - ZOSANO PHARMA CORP - COM NEW as of Q1 2021.
ZOSANO PHARMA CORP - COM NEW (ZSAN) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,088,335 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3,832,063 shares), Aisling Capital Management LP (2,718,226 shares), BlackRock Inc. (2,419,934 shares), GEODE CAPITAL MANAGEMENT, LLC (811,854 shares), NORTHERN TRUST CORP (199,497 shares), Telemetry Investments, L.L.C. (161,490 shares), CITADEL ADVISORS LLC (160,724 shares), BARCLAYS PLC (149,843 shares), GSA CAPITAL PARTNERS LLP (86,749 shares), and WINTON GROUP Ltd (64,558 shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.